ALLR · Allarity Therapeutics, Inc.
Market Cap
$22.43M
Shares
15.91M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$10,000,000
as of 2026-02-26
· total across 2 concurrent programs
Remaining Authorization
$4,928,833
as of 2026-06-30
Program Utilization
50.7%
$5,071,167 used of $10,000,000
| Program Announced | Authorized | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| 2026-02-26 | $5,000,000 | $4,928,833 | 2026-06-30 | 2027-03-01 | 10-Q , filed 2026-08-14 |
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2026-06-30 YTD | $262,000 | 10-Q, filed 2026-08-14 |
| 2025-12-31 | $3,190,000 | 10-K, filed 2026-03-30 |
| 2024-12-31 | $0 | 10-K, filed 2026-03-30 |